I’m not quite sure I see often pps jumping after large financings, some do most don’t, it’s what you do with the money that only counts, execution that garners significat positive trials, commercialization of products that ultimately get you much in revenue that is recurring, acquisitions paid and commitments done, then it’s a winner.